ALX Oncology Holdings, Inc. (ALXO)

1.46 +0.02 (+1.39%) USD  |  NASDAQ  |  Dec 09, 15:05
More

ALX Oncology Holdings EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ALXO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Prelude Therapeutics, Inc. Upgrade
Werewolf Therapeutics, Inc. Upgrade
Erasca, Inc. Upgrade
Immuneering Corp. Upgrade